Advancing Pharmacoequity in Atrial Fibrillation—The Case for Direct Oral Anticoagulants

Boursiquot, B. C., Jackson, L. R., & Essien, U. R. (2024). Advancing Pharmacoequity in Atrial Fibrillation—The Case for Direct Oral Anticoagulants. JAMA Network Open, 7(5), e249403. https://doi.org/10.1001/jamanetworkopen.2024.9403
Authors:
Brian C. Boursiquot
Larry R. Jackson
Utibe R. Essien
Affiliated Authors:
Brian C. Boursiquot
Columbia Affiliation:
Subjects:
Atrial Fibrillation (MeSH)
Anticoagulants (MeSH)
Atrial Fibrillation (OpenAlex Topic)
Antiplatelet Therapy in Cardiovascular Disease (OpenAlex Topic)
Economics of Pharmaceutical Research and Development (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1001/jamanetworkopen.2024.9403
PMID:
38709538
DOI:
10.1001/jamanetworkopen.2024.9403
Journal:
JAMA Network Open
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record

Record Created: